EarningsCENTRALPHL
CENTRALPHL Earnings Update
Announcement summary
- What happened
- CENTRALPHL published a corporate disclosure on 16 November 2022. Read the full announcement for details.
- Company
- Central Pharmaceuticals Limited
- Announcement published
Original announcement
(Q1 Un-audited): EPS was Tk. (0.08) for July-September, 2022 as against Tk. (0.08) for July-September, 2021. NOCFPS was Tk. 0.00 for July-September, 2022 as against Tk. 0.00 for July-September, 2021. NAV per share was Tk. 5.88 as on September 30, 2022 and Tk. 5.96 as on June 30, 2022.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 63746130b2c2584194ab7ab9
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from CENTRALPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.